SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-19-062109
Filing Date
2019-11-12
Accepted
2019-11-12 08:16:19
Documents
53
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm1919524d1_10q.htm 10-Q 517941
2 EXHIBIT 10.2 tm1919524d1_ex10-2.htm EX-10.2 11712
3 EXHIBIT 31.1 tm1919524d1_ex31-1.htm EX-31.1 12104
4 EXHIBIT 31.2 tm1919524d1_ex31-2.htm EX-31.2 11955
5 EXHIBIT 32.1 tm1919524d1_ex32-1.htm EX-32.1 5604
  Complete submission text file 0001104659-19-062109.txt   4215647

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT capr-20190930.xml EX-101.INS 1053808
7 XBRL TAXONOMY EXTENSION SCHEMA capr-20190930.xsd EX-101.SCH 33012
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE capr-20190930_cal.xml EX-101.CAL 36134
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE capr-20190930_def.xml EX-101.DEF 155828
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE capr-20190930_lab.xml EX-101.LAB 296951
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE capr-20190930_pre.xml EX-101.PRE 263071
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36598 | Film No.: 191206301
SIC: 2834 Pharmaceutical Preparations